Article Details

Wells Fargo & Co Upgrades Sunesis Pharmaceuticals (NASDAQ:SNSS) to Outperform

Retrieved on: 2017-12-28 08:10:55

Tags for this article:

Click the tags to see associated articles and topics

Wells Fargo & Co Upgrades Sunesis Pharmaceuticals (NASDAQ:SNSS) to Outperform. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC increased its holdings in Sunesis Pharmaceuticals by 1.1% during the first quarter. <b>Renaissance Technologies</b> LLC now owns 111,811 shares of the biopharmaceutical company's stock worth $458,000 after buying an additional 1,230 shares during the last quarter.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up